Combining Ezetimibe and Rosuvastatin: Impacts on Insulin Sensitivity and Vascular Inflammation in Patients with Type 2 Diabetes Mellitus

Bibliographic Details
Main Author:	Eun Roh
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2024-01-01
Series:	Diabetes & Metabolism Journal
Online Access:	http://e-dmj.org/upload/pdf/dmj-2023-0442.pdf

Comparative Efficacy of Rosuvastatin Monotherapy and Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity and Vascular Inflammatory Response in Patients with Type 2 Diabetes Mellitus
by: Ji Hye Han, et al.
Published: (2024-01-01)

Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial
by: Sang-Hyeon Ju, et al.
Published: (2024-03-01)

Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
by: Chilbert MR, et al.
Published: (2022-07-01)

Fixeddose combination of rosuvastatin + ezetimibe: ease of use, safety and efficacy
by: I. A. Alekseeva, et al.
Published: (2019-10-01)

Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
by: Sandeep Joshi, et al.
Published: (2017-12-01)

Features of using of a fixed combination of rosuvastatin and ezetimibe for effective hypolipidemic therapy
by: I. A. Alekseeva, et al.
Published: (2020-10-01)

Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9[S]
by: Brandon Ason, et al.
Published: (2011-04-01)

Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects
by: Kim CH, et al.
Published: (2017-12-01)

Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation
by: Minyoung Oh, et al.
Published: (2019-08-01)

Effect of High-Intensity Rosuvastatin vs. Combination of Low-Intensity Rosuvastatin and Ezetimibe on HbA1c Levels in Patients without Diabetes: A Randomized IDEAL Trial
by: Jeongcheon Choe, et al.
Published: (2023-09-01)

INFLUENCE OF ROSUVASTATIN ON VASCULAR ENDOTHELIUM FUNCTIONAL STATE AND SYSTEMIC INFLAMMATION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND DIABETES MELLITUS
by: I. M. Fushtey, et al.
Published: (2022-12-01)

The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study
by: Jun Sung Moon, et al.
Published: (2023-11-01)

An Efficient, Simultaneous Electrochemical Assay of Rosuvastatin and Ezetimibe from Human Urine and Serum Samples
by: Leyla Karadurmus, et al.
Published: (2022-11-01)

Stability Indicating Liquid Chromatographic Method for the Simultaneous Determination of Rosuvastatin and Ezetimibe in Pharmaceutical Formulations
by: Mathrusri Annapurna Mukthinuthalapati, et al.
Published: (2014-12-01)

The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial
by: Karolina Obońska, et al.
Published: (2017-07-01)

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
by: Gounari, P, et al.
Published: (2010)

Chemometric technique for the optimization of chromatographic system: Simultaneous HPLC determination of Rosuvastatin, Telmisartan, Ezetimibe and Atorvastatin used in combined cardiovascular therapy
by: V. Sree Janardhanan, et al.
Published: (2016-11-01)

Ezetimibe and diabetes mellitus:a new strategy for lowering cholesterol
by: V.A. Serhiyenko, et al.
Published: (2022-09-01)

Stability Indicating Liquid Chromatographic Method for the Simultaneous Determination of Rosuvastatin and Ezetimibe from Pharmaceuticals and Biological Samples
by: Sevinç KURBANOĞLU, et al.
Published: (2020-10-01)

Real-World Evidence Evaluation on the Lipid Profile, Therapeutic Goals, and Safety of the Fixed-Dose Combination of Rosuvastatin/Ezetimibe (Trezete®) in Dyslipidemia Patients
by: Joel Rodríguez-Saldaña, et al.
Published: (2022-01-01)

Dual Effect of Rosuvastatin on Glucose Homeostasis Through Improved Insulin Sensitivity and Reduced Insulin Secretion
by: Vishal A. Salunkhe, et al.
Published: (2016-08-01)

Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers
by: Kim H, et al.
Published: (2018-04-01)

NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE
by: N. I. Tarasov, et al.
Published: (2016-06-01)

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
by: Foody JM, et al.
Published: (2013-11-01)

Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial
by: Keun-Sik Hong, et al.
Published: (2023-05-01)

Impact of Ezetimibe on New‐Onset Diabetes: A Substudy of IMPROVE‐IT
by: Nishant P. Shah, et al.
Published: (2023-07-01)

SOMATOSTATIN INDUCTION OF PULSATILE INSULIN-SECRETION IN TYPE-2 DIABETES-MELLITUS - EFFECT ON INSULIN SENSITIVITY
by: Rice, H, et al.
Published: (1992)

Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double‐blind, multicenter, therapeutic confirmatory, phase III clinical trial
by: Chan Joo Lee, et al.
Published: (2024-03-01)

Evaluation of the efficiency and safety of therapy with a combination of sulfonylurea derivatives and insulin sensitizers for type 2 diabetes mellitus
by: O N Goncharenko, et al.
Published: (2012-08-01)

A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins
by: Alberico L. Catapano MD, PhD, et al.
Published: (2022-11-01)

Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition.
by: Chunmiao Tie, et al.
Published: (2015-01-01)

Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
by: Berne Christian, et al.
Published: (2005-06-01)

Age-Dependent Efficacy of Ezetimibe for Low-Density Lipoprotein Cholesterol Reduction in Japanese Patients with or without Type 2 Diabetes Mellitus
by: Satoshi Yamaguchi, et al.
Published: (2020-06-01)

Effects of rosuvastatin on serum glucose and insulin in hyperuricemic rats
by: Dilidaer Xilifu, et al.
Published: (2022-09-01)

EZETIMIBE (eze)
by: Marcela Botargues
Published: (2003-11-01)

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
by: Henri K Parson, et al.
Published: (2010-01-01)

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
by: Parson H
Published: (2010-01-01)

Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases
by: Won-Woo Seo, et al.
Published: (2022-05-01)

Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
by: Andrew Ahmann
Published: (2015-11-01)

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
by: Ian Hamilton-Craig, et al.
Published: (2010-11-01)

Combining Ezetimibe and Rosuvastatin: Impacts on Insulin Sensitivity and Vascular Inflammation in Patients with Type 2 Diabetes Mellitus

Similar Items

Similar Items